Search results
German pharmaceutical firm Merck lays cornerstone for research centre
dpa international via Yahoo Finance· 3 days agoGerman pharmaceutical and chemical company Merck is investing more than €300 million ($320 million)...
Sigma Planning Corp Sells 25,974 Shares of Merck & Co., Inc. (NYSE:MRK)
ETF DAILY NEWS· 6 days agoSigma Planning Corp reduced its stake in shares of Merck & Co., Inc. (NYSE:MRK – Free Report) by 56.2% during the 4th quarter, according to the company in its most recent ...
Merck and Bristol-Myers Squibb are bracing to lose their most lucrative patents
Quartz· 3 days agoPharma giants Merck and Bristol-Myers Squibb are both getting ready for some of their key drug...
Q3 2024 Earnings Forecast for Merck & Co., Inc. Issued By Leerink Partnrs (NYSE:MRK)
ETF DAILY NEWS· 7 days agoMerck & Co., Inc. (NYSE:MRK – Free Report) – Research analysts at Leerink Partnrs raised their Q3 2024 earnings per share estimates for Merck & Co., Inc ...
Merck Stock Climbs After Higher-Than-Expected Sales of Cancer Drug Keytruda
The Wall Street Journal· 3 days agoShares of U.S. drugmaker Merck are up nearly 4% in recent trading after the company said its...
Merck raises 2024 profit forecast on strong cancer, HPV drugs sales
WSAU Wausau· 3 days agoBy Patrick Wingrove (Reuters) - Merck & Co on Thursday raised its annual profit and revenue forecast...
Merck (MRK) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 3 days agoImage source: The Motley Fool. Merck (NYSE: MRK) Q1 2024 Earnings Call Apr 25, 2024, 9:00 a.m. ET Contents: Prepared Remarks Questions and Answers Call...
Analysts Set Merck & Co., Inc. (NYSE:MRK) Price Target at $131.25
ETF DAILY NEWS· 7 days agoMerck & Co., Inc. (NYSE:MRK – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the twelve research firms that are presently covering the stock ...
Merck Raises Forecast as Sales of Its Cancer Immune Therapy Soar
Bloomberg· 3 days agoMerck & Co. raised its annual profit and revenue forecast as the blockbuster cancer drug Keytruda...
Merck highlights progress on HIV, hypertension, cervical cancer drugs
WFMZ Eastern Pennsylvania and Western New Jersey· 3 days agoMerck got off to an excellent start in the first quarter of 2024. Wall Street met the news with...